Cuff tendinopathy. Unspecified rotator cuff tear or rupture of right shoulder, not specified as traumatic
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Men and women between the ages of 18 and 75 with cuff tendinopathy The availability of individual during the study period
Exclusion criteria
Exclusion criteria: People under the age of 18 and over 75 years Pregnant women or women who are breastfeeding People with malignancy,People with severe heart disease, uncontrolled diabetes mellitus, hemorrhagic diseases, history of anemia, arthritis, fibromyalgia and chronic fatigue syndrome Those linked to acetaminophen or Vicodin or a history of drug misuse History of cortisone injections in the last 6 weeks The use of non-steroidal anti-inflammatory drugs 1 week ago Having hemoglobin less than 11 g / dl and platelet count less than 150000 / mµ The use of inhibitors of platelet aggregation and anti-coagulation such as heparin History of cuff surgery in the last 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determining cuff pain by VAS in all phases of clinical trial. Timepoint: 1 and 3 months after the first injection. Method of measurement: Questionnaire (VAS).;Determination of cuff function by Shoulder Pain and Disability Index (SPADI) in all phases of clinical trial. Timepoint: 1 and 3 months after the first injection. Method of measurement: Questionnaire (SPADI).;Determine the range of cuff motion by manual joiniometry in all phases of clinical trial. Timepoint: 1 and 3 months after the first injection. Method of measurement: Range of motion (Degree). | — |
Countries
Iran (Islamic Republic of)
Contacts
Tabriz University of Medical Sciences